Randomized Phase II Trial on Primary Chemotherapy with High-Dose Methotrexate Alone or Associated with High-Dose Cytarabine for Patients with Primary CNS Lymphoma (IELSG #20 Trial): Tolerability, Activity and Event-Free Survival Analysis
Andrés JM Ferreri, Franco Cavalli(Institute of Social and Preventive Medicine), Maria Giuseppina Cabras(University of Cagliari), Maurilio Ponzoni(San Raffaele University of Rome), Monica Balzarotti(IRCCS Humanitas Research Hospital), Maurizio Martelli(Sapienza University of Rome), Alberto Franzin, Francesco Zaja, Alberto Fabbri(Azienda Ospedaliera Universitaria Senese), Nicoletta Anzalone, Fiorella Ilariucci(Azienda Sanitaria Unità Locale di Reggio Emilia), Daniele Vallisa(Ospedaliera di Piacenza), Caterina Stelitano(University of Reggio Calabria), Henry Gómez(National Cancer Center), Gian Marco Aondio, Attilio Guarini(Istituto Tumori Bari), Virginia Naso(Azienda ospedaliera "Bianchi-Melacrino-Morelli"), Catrina Uhlmann(Kantonsspital Aarau), María João Costa, Marina P. Siakantaris(National and Kapodistrian University of Athens), Maria K. Angelopoulou(Laiko General Hospital of Athens), Maurizio Frezzato(Ospedale San Bortolo), Marco Foppoli(San Raffaele University of Rome), Gaetano Corazzelli(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Alba A. Brandes(Istituto delle Scienze Neurologiche di Bologna), Luigi Rigacci(Azienda Ospedaliero-Universitaria Careggi), Riccardo Soffietti(Azienda Ospedaliero Universitaria San Giovanni Battista), Giuseppe Rossi(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Emanuele Zucca(Università della Svizzera italiana), Maria Cristina Tirindelli(Università Campus Bio-Medico), Graziella Pinotti(Medica (Italy)), Marta Gelemur(Instituto Argentino de Diagnóstico y Tratamiento), Michele Reni(San Raffaele University of Rome), F. Caligaris Cappio, Giuseppe Avvisati(Università Campus Bio-Medico)
Cited by 7
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer
|New England Journal of Medicine|2019|2.2k
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
|Journal of Clinical Oncology|2010|2k
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k